Pre-earnings options volume in Aldeyra (ALDX) is normal with calls leading puts 2:1. Implied volatility suggests the market is anticipating a move near 30.8%, or $2.06, after results are released. Median move over the past eight quarters is 2.2%.
Claim 50% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on ALDX:
- Aldeyra Therapeutics: Buy Rating Affirmed on Promising Reproxalap and Strategic RASP Market Expansion
- Biotech Alert: Searches spiking for these stocks today
- Aldeyra Therapeutics: Strategic Pipeline Advancements and Financial Stability Drive Buy Rating
- Optimistic Buy Rating for Aldeyra Therapeutics Amid Promising FDA Review and Potential AbbVie Collaboration